[The Epoch Times, January 24, 2022](The Epoch Times reporter Chen Guang, Sydney, Australia compiled and reported) Australian Health Minister Greg Hunt said on Monday (24th) that a recombinant protein vaccine against COVID-9 (CCP virus) The Novavax vaccine is fully approved for use in Australia. The vaccine will begin rolling out the week of February 21.
Hunter confirmed at a press conference in Victoria that the Australian Technical Advisory Group for Immunization (ATAGI) had approved the Novavax vaccine for use in Australia.
“The specific recommendation from the Australian Immunization Technical Advisory Group is that it will be a two-dose course with at least three weeks between the first and second doses,” he said.
Last week, Australia’s Therapeutic Goods Administration (TGA) approved an application for the Novavax vaccine to be used in Australia.
Novavax vaccine is a vaccine produced by protein sub-unit technology. The principle is to screen out the pathogenic protein from the viral coat protein, implant the protein DNA sequence into cells with genetic engineering technology, cultivate the viral protein, purify it, and then inject it into the human body.
The Australian government has ordered 51 million doses of the Novavax vaccine.
For those who may have contraindications or reactions to other types of Covid-19 vaccines, as well as those who for some reason have not yet been vaccinated, the launch of the Novavax vaccine will help them, Hunt said. provide an additional opportunity.
The Novavax vaccine will be used in conjunction with the three vaccines currently available in Australia: Pfizer, Moderna and AstraZeneca.
Responsible editor: Li Ziyin
For more real-time news and life information in Australia, please click dajiyuan.com.au
(This article may not be reproduced or established a mirror website without permission)